Joyce Lee - Zoetis President

<div class='circular--portrait' style='background:#2A0CD0;color: white;font-size:3em;padding-top: 35px;;'>ZTS</div>
ZTS -- USA Stock  

Earning Report: February 13, 2020  

Ms. Joyce J. Lee serves as Executive Vice President Area President of the Canada and Latin America region of Zoetis Inc. Ms. Lee was Area President of the same region for Pfizer Animal Health from 2010 to 2012
Age: 41  President Since 2012      
973 822-7000
Lee joined Pfizer in 2003 with its acquisition of Pharmacia and held various positions, including Vice President of Global Poultry and Vice President of Global Business Technology, for Pfizer Animal Health.

Joyce Lee Latest Insider Activity

Management Efficiency

The company has Return on Asset of 10.7 % which means that on every $100 spent on asset it made $10.7 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 0.01 % implying that it generated $0.01 on every 100 dollars invested.
The company has 6.66 B in debt with debt to equity (D/E) ratio of 248.5 . This implies that the company may be unable to create cash to meet all of its financial commitments. Zoetis has Current Ratio of 4.3 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives


Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
Douglas McCorkleRegeneron Pharmaceuticals
Sripada ChandrasekharDr Reddys Laboratories Ltd
Thomas GraneyVertex Pharmaceuticals Incorpor
John WesolowskiPerrigo Company Plc
Peter PowchikRegeneron Pharmaceuticals
James DillardPerrigo Company Plc
K RaoDr Reddys Laboratories Ltd
Svend AndersenPerrigo Company Plc
John GrayVertex Pharmaceuticals Incorpor
Michael AbermanRegeneron Pharmaceuticals
Christopher FenimoreRegeneron Pharmaceuticals
Amit SachdevVertex Pharmaceuticals Incorpor
Jay MarkowitzRegeneron Pharmaceuticals
Paul SilvaVertex Pharmaceuticals Incorpor
Ronald JanishPerrigo Company Plc
Michael PariniVertex Pharmaceuticals Incorpor
Saumen ChakrabortyDr Reddys Laboratories Ltd
Umang VohraDr Reddys Laboratories Ltd
Douglas BoothePerrigo Company Plc
Marion McCourtRegeneron Pharmaceuticals

Entity Summary

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 10000 people.Zoetis (ZTS) is traded on BATS Exchange in USA and employs 10,000 people.

Zoetis Leadership Team

Roman Trawicki, Executive Vice President and Presidentident of Global Manufacturing and Supply
Kristin Peck, Chief Executive Officer, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy, Director
William Steere, Independent Director
Roxanne Lagano, Executive Vice President, Chief Human Resources Officer and Communications
Linda Rhodes, Independent Director
Frank DAmelio, Independent Director
Robert Scully, Independent Director
Clinton Lewis, Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human Medical Diagnostics
Stefan Weiskopf, Executive Vice President and Area President of the Asia Pacific, Australia and New Zealand
Sanjay Khosla, Independent Director
Paul Herendeen, CFO and Executive VP
Catherine Knupp, Executive Vice President, President - Research and Development
Michael McCallister, Non-Executive Independent Chairman of the Board
Paul Bisaro, Independent Director
Alejandro Bernal, Executive Vice President and Area President of the Europe, Africa and Middle East region
Willie Reed, Independent Director
Joyce Lee, Executive Vice President and Area President of the Canada and Latin America region
Glenn David, Chief Financial Officer, Executive Vice President
Sandra Beaty, Executive Vice President - Corporate Affairs
William Doyle, Director
Andrew Fenton, Executive Vice President and Chief Digital and Technology Officer
Gregory Norden, Independent Director
Louise Parent, Independent Director
Heidi Chen, Executive Vice President General Counsel, Corporate Secretary
Juan Alaix, Chief Executive Officer, Director

Stock Performance Indicators

Did you try this?

Run Portfolio Diagnostics Now


Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Module

Also Currentnly Active

Purchased over 90 shares of
few hours ago
Traded for 53.0
Purchased few shares of
few hours ago
Traded for 414.94
Purchased over 100 shares of
few hours ago
Traded for 138.0
See also Your Current Watchlist. Please also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.